Vera Therapeutics (VERA) announced that it has completed full enrollment in the pivotal ORIGIN Phase 3 trial of atacicept in patients with IgA ...
On track to announce primary endpoint result from ORIGIN 3 trial this quarter (2Q 2025)U.S. FDA BLA submission for ...
Jonathan Porter, former Chief Product Officer, has been promoted to Chief Executive Officer of the company. With the leadership change, the company is also ...
Koning Health proudly announces its continued nationwide expansion, with new installations of the Vera Scan coming soon to eight prominent locations across the United ...
Learn more about whether Corcept Therapeutics Incorporated or Novartis AG is a better investment based on AAII's A+ Investor ...
American Century Companies Inc. grew its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 11.0% ...
Learn more about whether Alvotech or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
This article explores the science-backed benefits of aloe vera for gut health, potential risks, and the best ways to ...
Nearly all nephrologists agree that early and aggressive intervention is essential for improving outcomes in IgA nephropathy (IgAN). However, findings from Spherix’s ...